INTRODUCTION
Medullary thyroid carcinoma (MTC) is a malignant tumor originating from parafollicular C cells that produce calcitonin and accounts for 5-10% of all thyroid cancers. MTC develops in either sporadic (75%) or hereditary form (25%). In the inherited form, MTC appears in three cancer syndromes: FMTC (familial medullary thyroid carcinoma), MEN2A and MEN2B (multiple endocrine neoplasia type 2).
The hereditary form of MTC is associated with the development of germline changes in the RET gene. The RET (REarranged during Transfection) gene localized to 10q11.2 was identified in 1985 (1) . The RET gene encodes a receptor tyrosine kinase and is expressed in the neural crest cells and neural crest-derived tissues (2, 3) . The germline mutations of the RET gene causing increased receptor activation (gain-of-function mutations) are responsible for the FMTC, MEN2A (e.g. exon 10, codons 609, 611, 620) and MEN2B (e.g. exon 16, codon 918) cancer syndromes, while germline mutations of the RET gene leading to loss of receptor tyrosine kinase activity (loss-of-function mutations) are responsible for the development of Hirschsprung's disease (4, 5) .
In our earlier article we presented a spectrum of the RET gene mutations prevalent in the population of Central Poland (6) . It represents the majority of mutations of this gene reported in the world literature (7, 8, 9) . The highest number of mutations were identified at codons 634 (26.8%) and 791 (20.9%).
In the RET gene, apart from clearly pathogenic mutations, also polymorphic changes in the DNA sequence were found. These are frequent changes (frequency above 1%) of several nucleotides in the DNA of the human population. They are divided into: mini and microsatellite sequences polymorphisms and single nucleotide polymorphisms (SNPs).
SNPs make up about 90% of all the human genome variations and occur every 100 to 300 bases along the 3-billion-base human genome (10) .
A SNP in which the amino acid sequence of protein that is produced is altered due to single nucleotide polymorphism is termed non-synonymous. Synonymous SNPs do not lead to a change in the amino acid sequence. Studies conducted over the past few years revealed the effect of synonymous mutations on predisposition to develop cancer. To date, several types of SNPs have been identified in the RET gene: G691S/exon 11, GTT/AGT; L769L/exon 13, CTT/CTG; S836S/exon 14, AGC/AGT; S904S/exon 15, TCC/TCG. These changes were present both in affected individuals (endocrine tumors, MTC, PTC, HSCR) as well as in the non-affected population (11, 12) . Among the several known SNPs, only one change, in exon 11 G691S, results in the substitution of another amino acid in the protein chain (13).
In our group of patients three types of single-nucleotide polymorphisms were found in the RET gene in exons 13 (L769L), 14 (S836S) and 15 (S904S). These molecular variants appeared in one or both alleles of affected and non-affected individuals.
The aim of our study was to compare the frequency of occurrence of three SNPs: L769L, S836S and S904S, in patients with sporadic medullary thyroid carcinoma and in nonaffected individuals. Furthermore, we studied the effect of carrying homo-and heterozygous polymorphic variant L769L on the age at onset of the sporadic and familial medullary thyroid carcinoma.
MATERIALS AND METHODS

Patients
246 patients, from Central Poland, with histological changes consistent with medullary thyroid cancer (MTC), treated at the Warsaw Oncology Centre in the years 1998-2007, were assessed. Out of that number, 217 were not found to be carriers of the known pathogenic mutations and were diagnosed as having sporadic medullary thyroid cancer. All patients with diagnosed sMTC were examined in respect of occurrence of other germline mutations in exons: 10, 11, 13, 14, 15 and 16, in which changes connected with hereditary MTC were detected. The other 29 patients were found to be carriers of mutations in codons 791 (9 patients) and 634 (19 patients).
Assessments were also performed in 11 non-affected carriers of codon 791 mutations and 3 non-affected carriers of codon 634 mutations.
All patients were subjected to the following standard diagnostic procedures: laboratory tests for serum CEA and calcitonin (basal and in some cases also stimulated levels), calcium, PTH, catecholamines and their urinary metabolites, neck ultrasound scanning, abdominal ultrasound scanning including adrenal gland area evaluation, echocardiography and ABP (ambulatory blood pressure monitoring). Peripheral blood sample was taken for genetic testing.
The frequency of occurrence of molecular variants in the population was evaluated by testing anonymous blood samples of neonates from Central Poland. The presence of the L769L and S904S molecular variants were analyzed in 420 blood samples and of the S836S molecular variant in 411 blood samples.
Methods
The genomic DNA of the studied individuals was isolated from peripheral blood lymphocytes. Four fragments of the RET gene: exons 13, 14, 15 and 11 were amplified using the PCR technique, in which the frequency of occurrence of SNP was studied. The product of the sequencing reaction was subjected to electrophoresis on 5% denaturing polyacrylamide gel in a Perkin Elmer ABI Prism 377 DNA sequencer. Detailed information can be found in publication Paszko et al 2007 (6) .
Statistical Analysis
The statistical analysis of the frequency of polymorphic variants was performed using Chi-square (χ 2 ) test with Yates' Correction. The difference calculated with the probability margin of p<0.05 was deemed statistically significant. When analyzing the age at onset of the disease in the studied groups, median ages at onset were compared using Mann-Whitney test.
Bioinformatics Analysis mRNA sequence was taken from NCBI nucleic database, divided to shorter partsexons -and folded by RNAfold software from RNA ViennaPackage (14) . RNAfolding algorithm counts energy parameters, and their values depend on sequence length. The reason is that if RNA molecule is long enough, the probability of the predicted structure with minimal free energy (MFE) is very low, because the amount of possible secondary structure grows expotentially with the length of the sequence. In these experiments we wanted to observe the possible influence of one nucleotide change on the energy of the sequence. This change cannot be observed if we consider the whole RET sequence -its length is 3345 nucleotides. Considering small fragments, allows us to observe local energy parameters and stabilization differences. The structures were visualized by VARNA software (Visualization Applet for RNA) (15) .
RESULTS
A total of 124 cases of homo-and heterozygous molecular variants L769L (57.14%)
were identified in the 217 MTC patients assessed; 202 cases of homo-and heterozygous molecular variants L769L (48.09%) were identified in the 420 samples collected from the control group, OR: 1.43; p=0.0374. The frequency of the individual alleles in the case of the polymorphic change L769L differed from the frequency of these alleles in the control group. χ2 statistical analysis showed these differences to be statistically significant, OR: 1.43; p=0.0394, Table 1 .
The analysis of the polymorphic variant S836S in exon 14 and S904S in exon 15 of the RET gene showed no statistically significant difference in the frequency of heterozygotes and homozygotes between MTC patients and non-affected individuals. Table 1 .
Furthermore, we analyzed whether the presence of the polymorphic change L769L in patients with sporadic medullary thyroid carcinoma affected the age at onset of the disease.
Thus, using Mann-Whitney test we compared the median ages at onset of the disease in the three groups of MTC patients carrying different polymorphic variants: CTT/CTT, CTT/CTG and CTG/CTG, Table 2 . The results showed that the age at onset of the disease in carriers of the homozygous polymorphic change CTG/CTG was 11.5 years lower than the age at onset in individuals with the wild-type nucleotide sequence CTT/CTT. The difference between the median ages at onset between these two groups was statistically significant (p=0.021). Similarly, the age at onset in carriers of the homozygous change CTG/CTG was 14.5 years lower than the age of affected carriers of heterozygous polymorphic change CTT/CTG. The difference between the compared groups was also statistically significant (p=0.015), Table 2 .
In the studied group of MTC patients the polymorphic change L769L was accompanied by a F791Y mutation in exon 13. Each patient carrying mutation F791Y had at the same time SNP L769L, Table 3 . The most frequently occurring mutation in the studied patients was the RET exon 11 codon 634 mutation. In carriers of these mutations at codon 634 (C634R, C634S, C634G) the polymorphic change L769L occurred in only 59,0% of cases, Table 3 . The age at onset in carriers of RET codon 634 mutations and SNP L769L was 23 years lower than in patients carrying only the mutation at codon 634. The difference between the median ages at onset in both groups of patients was significant p=0.0072, Fig. 1 The obtained results induced us to carry out bioinformatics analysis of the changes that may occur during genetic information reading of the studied RET gene fragments. The simplest prediction of mRNA structure is a prediction of thermodynamic stable structure, minimal free energy structure (MFE). The result of this method is shown in Table 4 .
Differences in minimal free energy between wild types and mutants are less than 5% in the case of SNP's S904S, S836S and mutations Y791F and C634R. No effect on MFE is visible also in the combination of C634R and SNP L769L.
Only in the case of exon 13 and SNP the difference is noticeable. SNP reduces the energy of the wild-type by 17%, and the mutant Y791F by 7%. It can be concluded that only SNP L769L reduces the minimal free energy of small mRNA fragment (in the longer part of sequence -from exon 11 to 13, the effect is not visible). Fig. 2 shows the predicted MFE structures of exon 13. The effect of one mutated nucleotide is visible -it changes the MFE structure in wild type and mutated sequence.
However, it is known that mRNA is unlikely to adopt a single stable conformation. It rather exists as a population of structures -RNA molecules fold to a metastate, which alternates between a number of closely related structures (16) . Therefore recently ensemblebased approaches to structure prediction are more popular. The results of ensemble diversity and the free energy of the thermodynamic ensemble are shown also in Table 4 . Evident differences between exons are visible in case of ensemble diversity (the average base-pair distance between all structures in the Boltzmann ensemble).The base-pair distance is defined as the number of base-pairs not shared by two structures. Lower ensemble diversity means that more base pairs are shared in the ensemble of predicted structures, so RNA structure is more stable.
All tested mutations reduced the value of ensemble diversity. Pathogenic mutations have negligible effect: Y791F reduce the value by 6.6% and C634R only by 1.86%. On the other hand, SNPs reduced S836S by 13% and SNP S904S by 29%.
Greater change is visible in the fragment of joined exons (11, 12, 13) : SNP L769L reduces the ensemble diversity of exon 13 by 10.68% and of exon having a pathogenic mutation (C634R) by 10.91%. Again, the greatest change is visible in exon 13: SNP L769L reduces the ensemble diversity of exon 13 up to 76% and of exon having a pathogenic mutation (Y791F) up to 53%. in MTC patients and the control group to be 23% and 27%, respectively. The dissimilarity of results obtained by Wiench et al. (22) and in our study was most likely due to regional differences in the frequency of the polymorphic variants in the Polish population.
DISCUSSION
An important aspect of our study was to investigate the effect of the presence of the polymorphic change L769L in the RET gene on the age at onset in patients with sporadic MTC. We found that the age at onset in carriers of the homozygous change L769L was significantly lower than in carriers of the wild nucleotide, Table 2 . These findings clearly showed that homozygous polymorphic changes could act as modifiers in the development of sporadic medullary thyroid carcinoma. Wiench et al. (22) found increased frequency of the L769L polymorphism in younger (aged <30) patients with sporadic MTC from Silesia Province, however, the difference in frequency compared with the control group was not statistically significant. Gursoy et al. (20) however, found no significant differences in the age at onset of sporadic MTC between younger patients (under 40 years of age) carrying polymorphism L769L and the group of older patients (over 40 years of age).
We have made an interesting observation concerning carriers of pathogenic germline mutations at codon 634 and the polymorphic variant L769L. Apparently, the age at onset of the disease in carriers of the germline mutation and the polymorphic variant was lower than in carriers of only the RET codon 634 pathogen mutation, Fig. 1 .
In our material, similarly as Baumgartner-Parzer et al. (12) , we found that individuals harbouring a RET codon 791 mutation always harboured the L769L polymorphism as well.
As the most recent data (6, 24) suggested, mutation F791Y may be much more frequent than it had previously been thought to occur.
In the studied material, unlike in the case of the polymorphic change L769L, the analysis of the frequency of the polymorphic variant S836S occurring in exon 14 of the RET gene showed no statistically significant differences in the frequency of heterozygous polymorphisms between patients with sporadic MTC and the control group. Our results match the findings of other authors (12, 13; 22, 25) who found no significant differences in the frequency of these changes between patients with sporadic MTC and non-affected individuals.
However, many authors (26, 27, 28) claim that the molecular variant S836S in the RET gene plays a more important role in the pathogenesis of MTC. Griseri et al. (29), suggested that the polymorphic variant S836S could increase RET receptor TK activity (similarly to the germline gain-of-function mutation). In the authors' opinion, the polymorphic change S836S could lead to incorrect protein synthesis or amino acid substitution in the protein caused by similarity and erroneous recognition of aminoacyl-tRNA.
Robledo et al. (30) noticed that G691S/S904S haplotype of RET may influence the age at onset in MEN2A patients. The change G691S is mainly responsible for that effect, however it cannot be ruled out that polymorphic change S904S can lead to production of different amounts of mRNA. The frequency of the polymorphic change S904S in our study population is similar in the study and control groups. The occurrence of the polymorphic change itself is, probably, not a factor predisposing to MTC development. It is possible, however, that the occurrence of that polymorphic variant, accompanying other more serious changes, can accelerate and modify the oncogenic effect induced by those changes.
The mechanisms by which polymorphic changes in the RET gene affect synthesis of the protein encoded by this gene are still not properly understood. It is presumed that their activity results in interrupted transcript splicing. As early as in the late 90s, Borrego et al. (26) put forward a thesis that polymorphic variants may cause new, alternative splicing sites (acceptor, donor or enhancer) to appear, which lead to the synthesis of incomplete proteins or erroneous ligand binding, microRNA binding, change of structure and mRNA stability as well as a number of copies and also the change in the structure of proteins caused by interference (slowing down) of translation (31, 32) Our analyses based on bioinformatic methods made possible to draw several conclusions concerning mRNA conservation in the case of presence of various polymorphic variants in the RET gene.
Codon usage bias refers to differences among organisms in the frequency of occurrence of synonymous codons in mRNA. Optimal codons reflect the composition of their respective genomic tRNA pool. It is thought that using optimal codons help to achieve faster translation rates and higher accuracy. Folding of the beta sheet occurs slower than the alpha helix formation (33). If translation rate is changing before the process of beta sheet formation is finished, newly synthesized sequence influence the structure earlier (or later) then usual and may effect on the folding of the protein. If the mutation is a change of optimal to less frequent codon, it can lead to translation or protein folding disorders, because of ribosome stalling (pause). SNP S836S and S904S are changes to less frequent codons, so ribosome stalling can happen. In case of SNP L679L, where the codon with higher codon usage appear, the sheet may not finish creating the structure, when helix appears (34), Tab.5. As a consequence, there is not enough space to create the appropriate structure. This can lead to changes in kinase activity and/or specificity and, as a result, influence disease sympthomes.
We may thus assume, on the basis of the studies conducted, that the molecular polymorphic variants in the RET gene play a very important role in the predisposition to sporadic medullary thyroid carcinoma and modify the age at onset of this disease. The research covered a group of 210 patients for whom age at onset of symptoms of sporadic MTC could be established
Wild type(A), heterozygous change (B), homozygous change (C). All patients were non-carriers of pathogenic mutations in gene RET. and/or synonymous mutation SNP L769L (CUU → CUG); exon 14 with synonymous mutation SNP S836S (AGC → AGU); exon 15 with synonymous mutation SNP S904S
(UCC → UCG); exons 11-13 with pathogenic mutation C634R (TGC → CGC) and/or synonymous mutation SNP L769L (CUU → CUG).
Minimum free energy, ensemble diversity and the free energy of the thermodynamic ensemble are predicted by RNAfold software as described in materials and methods.
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